Page 5 of 22
GEMS – September 2017
GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance. Drug-resistance testing in Kenya progresses. GEMS prepares for drug-resistance testing in South Africa and Zimbabwe. Genital swabs testing begins and assay development is underway. Oral PrEP modeling continues. Drug-resistance testing in Kenya progresses. The GEMS team… Read more »
CHARISMA – September 2017
CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV). Clinic- and community-based interventions continue. Intervention evaluations and reporting planned. Clinic- and community-based interventions continue. CHARISMA is piloting its clinic-based intervention as part… Read more »
Page 5 of 22